Cepheid Gets FDA Approval for Xpert CT/NG
Delivering Rapid Detection and Differentiation of Chlamydia and N. gonorrhoeae
Read MorePosted by Judy O'Rourke | Dec 28, 2012 | Infectious Diseases, Sexually Transmitted Diseases |
Delivering Rapid Detection and Differentiation of Chlamydia and N. gonorrhoeae
Read MorePosted by Judy O'Rourke | Dec 26, 2012 | Miscellaneous |
Two-day diagnostic for childhood genetic disease reduces wait times by months.
Read MorePosted by Judy O'Rourke | Dec 24, 2012 | Miscellaneous |
A look back at key industry advances in 2012 and ahead to opportunities and challenges in 2013.
Read MorePosted by Judy O'Rourke | Dec 24, 2012 | Cancer, Miscellaneous |
CLP recently spoke with David Hout, PhD, VP of R&D, Insight Genetics, about continuing work on the Insight ALK Screen, Insight ALK Resistance, and other biomarker-specific diagnostic tools to advance cancer care.
Read MorePosted by Judy O'Rourke | Dec 21, 2012 | Cancer, Miscellaneous |
A 5-year, $1.3 million grant from the NIH funds an innovative program to help pathologists understand genomics information and serve as primary consultants for physicians and patients in interpreting and acting on this data.
Read More